[[abstract]]Cancer patients are at lower risk of developing Parkinson's disease (PD) compared with the general population. One explanation is the negative association between smoking and PD, but PD risk is also lower for cancers not related to smoking. Another explanation is survival bias where death from cancer may act as a competing risk. We conducted a large population-based case-control study in Denmark and investigated whether cancer diagnosis reduced the risk of developing PD even after adjusting for important risk factors including smoking, physical activity, and lifetime oestrogen status. Using probabilistic bias analysis we quantified the influence of survival bias. We estimated negative point estimates (ORs) between cancers and PD...
Background: Epidemiological data suggest that cancer patients have a reduced risk of subsequent Par...
BACKGROUND To examine the site-specific cancer mortality among deaths registered with Parkinson's d...
ImportancePatients with Parkinson disease (PD) who harbor LRRK2 G2019S mutations may have increased ...
[[abstract]]Cancer patients are at lower risk of developing Parkinson's disease (PD) compared with t...
Cancer patients are at lower risk of developing Parkinsons disease (PD) compared with the general po...
[[abstract]]Cancer patients are at lower risk of developing Parkinson’s disease (PD) compared with t...
Cancer patients are at lower risk of developing Parkinson’s disease (PD) compared with the general p...
Background: Prior studies suggest a decreased risk of cancer among patients with Parkinson’s disease...
International audienceWe investigated the risk of cancer after the diagnosis of Parkinson's disease ...
BACKGROUND: Several studies suggest that cancer is reduced before and after a Parkinson\u27s disease...
Lower cancer risk in Parkinson\u2019s disease (PD) patients compared to the general population has b...
OBJECTIVE: To examine how use of medical care biases the well-established associations between Parki...
This dissertation work investigates two types of biases in population-based studies of Parkinson’s d...
Among 14,088 patients, with a primary diagnosis of Parkinson's disease during the period 1977-98 ide...
Epidemiological evidence suggests a reduced incidence of many common types of cancers in individuals...
Background: Epidemiological data suggest that cancer patients have a reduced risk of subsequent Par...
BACKGROUND To examine the site-specific cancer mortality among deaths registered with Parkinson's d...
ImportancePatients with Parkinson disease (PD) who harbor LRRK2 G2019S mutations may have increased ...
[[abstract]]Cancer patients are at lower risk of developing Parkinson's disease (PD) compared with t...
Cancer patients are at lower risk of developing Parkinsons disease (PD) compared with the general po...
[[abstract]]Cancer patients are at lower risk of developing Parkinson’s disease (PD) compared with t...
Cancer patients are at lower risk of developing Parkinson’s disease (PD) compared with the general p...
Background: Prior studies suggest a decreased risk of cancer among patients with Parkinson’s disease...
International audienceWe investigated the risk of cancer after the diagnosis of Parkinson's disease ...
BACKGROUND: Several studies suggest that cancer is reduced before and after a Parkinson\u27s disease...
Lower cancer risk in Parkinson\u2019s disease (PD) patients compared to the general population has b...
OBJECTIVE: To examine how use of medical care biases the well-established associations between Parki...
This dissertation work investigates two types of biases in population-based studies of Parkinson’s d...
Among 14,088 patients, with a primary diagnosis of Parkinson's disease during the period 1977-98 ide...
Epidemiological evidence suggests a reduced incidence of many common types of cancers in individuals...
Background: Epidemiological data suggest that cancer patients have a reduced risk of subsequent Par...
BACKGROUND To examine the site-specific cancer mortality among deaths registered with Parkinson's d...
ImportancePatients with Parkinson disease (PD) who harbor LRRK2 G2019S mutations may have increased ...